RYGAPT
LIVE

Serial Number

79189845

Owner

NOVARTIS AG

Filing Date

Jun 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

RYGAPT Trademark

Serial Number: 79189845 • Registration: 5098033

RYGAPT is a trademark filed by NOVARTIS AG on June 24, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 24, 2016

Registration Date

December 13, 2016

Published for Opposition

September 27, 2016

Cancellation Date

August 7, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 9, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 9, 2020 DETH
NOTIFICATION PROCESSED BY IB
Oct 27, 2017 GPNX
NOTIFICATION PROCESSED BY IB
Mar 3, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Feb 15, 2017 FICS
FINAL DISPOSITION PROCESSED
Feb 15, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 12, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2016 R.PR
PUBLISHED FOR OPPOSITION
Sep 27, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 7, 2016 OP2R
NOTICE OF PUBLICATION
Sep 7, 2016 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2016 CNSA
APPLICATION FILING RECEIPT MAILED
Aug 12, 2016 MAFR
ASSIGNED TO EXAMINER
Aug 9, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 5, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 4, 2016 SDRC